Senior Director, Head of Clinical Pharmacology & DMPK
NGM Biopharmaceuticals
Dr. Yan has over 15 years of experience in DMPK, clinical pharmacology, and pharmacometrics for biologics and small molecules spanning from discovery to Phase 4 across diverse therapeutic areas. Currently, she serves as Senior Director and Head of Clinical Pharmacology and DMPK at NGM Biopharmaceuticals. In this role, Dr. Yan leads the clinical pharmacology and DMPK functions, develops and implements long-term and short-term strategies, and oversees technical execution across all aspects of clinical pharmacology to drive pipeline advancement.
Previously, Dr. Yan held positions as Director and Senior Director of Clinical Pharmacology and DMPK at Horizon Therapeutics and Viela Bio, where she led the clinical pharmacology efforts for global filings, defenses, and approvals of UPLIZNA®. Prior to her roles at Horizon/Viela Bio, Dr. Yan held positions with increasing responsibilities at AstraZeneca, Certara, and UCSF, where she accrued in-depth knowledge of drug development process from IND through LCM, with a track record of successful IND/BLA/MAA submission, defense, and approval (e.g. FASENRA® and FASENRA® Self-Administration).
Dr. Yan received her Ph.D. from the UCSF/UC Berkeley Joint Program in Bioengineering. She has a solid publication record, contributing to over 50 peer-reviewed manuscripts and abstracts/posters.